Labelling, Vaccines and White Paper

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. Credit: Saiful52 / Shutterstock.

Labelling

Labelling Packaging Communication Hospitals

FDA approves label expansion of AbbVie hepatitis C therapy

Pharmaceutical Technology

JUNE 13, 2025

The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir) for treating adults and paediatric patients three years and older with acute or chronic hepatitis C virus (HCV) infection. Credit: © AbbVie Inc. All rights reserved.

Labelling

Labelling Communication Hospitals Vaccines

FDA removes safety programme for CAR-T therapies to boost uptake

Pharmaceutical Technology

JUNE 30, 2025

How will RFK Jr’s American dream for vaccines play out? The agency said that safety information can be adequately conveyed using drug product labelling. This includes a boxed warning for the risks of CRS and neurological toxicities.

Insurance Coverage and Processing

Insurance Coverage and Processing Packaging Labelling Communication

Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn

Pharmaceutical Technology

JUNE 30, 2025

How will RFK Jr’s American dream for vaccines play out? of equity shares from JB employees at the same price per share as offered to KKR. of equity shares from JB employees at the same price per share as offered to KKR.

Packaging

Packaging Communication Hospitals Drug Pricing

Vetter breaks ground on $285m US clinical manufacturing site

Pharmaceutical Technology

JUNE 30, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Hospitals Compounding Communication

Africa’s growing vaccine capacity

Quality Matters

FEBRUARY 9, 2023

Africa’s growing vaccine capacity Manufacturing products locally for more equitable pandemic responses Every year, vaccines prevent nearly 5 million deaths around the globe. Yet, Africa produces less than 1 percent of the vaccines it needs to protect patients and communities across the continent.

Vaccines

Vaccines Immunity Immunization Labelling

EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL

Pharmaceutical Technology

JUNE 16, 2025

At the 2025 Congress of the European Hematology Association (EHA 2025), held from 12 June 12 to 15 June in Milan, Italy, preliminary dose-escalation and optimisation results from the global, multicentre, open-label, single-arm Phase I/II SYRUS clinical trial (NCT06137118) were presented on the second day.

Labelling

Labelling Communication Hospitals Vaccines

WHO accuses China of withholding Covid-19 genetic data

Pharmaceutical Technology

JUNE 30, 2025

How will RFK Jr’s American dream for vaccines play out? This includes understanding how different modalities of vaccines work, which has knock-on effects for supply chain logistics and manufacturing coordination. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Vaccines

Inflation, drug pricing and reimbursement constraints will challenge pharma sector

Pharmaceutical Technology

JANUARY 5, 2023

The swift development of COVID-19 vaccines was an unprecedented scientific and collaborative achievement by government, regulators, research institutions, and the pharmaceutical industry. The pharmaceutical industry has long been labelled as a recession-proof—stable demand for medicines and new treatment options acts as a protective barrier.

Drug Pricing

Drug Pricing Vaccines Labelling Communication

How Berlinger’s climate-focused innovation is helping to reduce, remove and offset emissions from the pharmaceutical supply

Pharmaceutical Technology

SEPTEMBER 16, 2022

And despite the recent pandemic that forced the industry to develop and deliver treatments and vaccines all over the world, the issue of reducing emissions has remained high on industry leaders’ agendas. Download the white paper to learn more. [1] Industry awareness of the issues. Linda Schwär, VP Marketing, Berlinger & Co.

Vaccines

Vaccines Labelling

CMO Moves: Regulatory catalysts for drug manufacturing – March 2023

Pharmaceutical Technology

MARCH 21, 2023

A few weeks later, the EC extended the approval label of AstraZeneca’s Forxiga (dapagliflozin) to include the treatment of symptomatic hearth failure. The vaccine ACI-24.060 elicited an anti-Abeta antibody response in the first patient cohort after six weeks, as per the results.

Packaging

Packaging Vaccines Labelling Communication

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Tensions escalated in late January when the company scrapped a £450m plan to turn its Speke-based facility into a major vaccine hub, after failing to reach an agreement with government ministers over the level of state support.

Chemotherapy

Chemotherapy Packaging Labelling Communication

Sarepta and Roche halt DMD gene therapy’s use after second death

Pharmaceutical Technology

JUNE 16, 2025

By GlobalData Learn more about Strategic Intelligence Corwin added that Elevidys’s label will likely be updated to reflect the risk of ALF. Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Hospitals Vaccines

Moderna shines spotlight on new flu vaccine data

pharmaphorum

JUNE 30, 2025

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Vaccines Diabetes Pharmaceutical Companies Pharmaceutical Companies

Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older.

Vaccines

Vaccines Insurance Coverage and Processing Labelling Communication